Supplying Tocotrienols to Drive Longevity
We are working to provide the ounce of prevention.
”It would be no exaggeration to call it nature’s best kept secret, if not the most promising natural substance in influencing health and disease”
- Ahmad Farouk Musa, Monash University Malaysia
Welcome to H&G Science, the advanced biotechnology manufacturing, research and development team paving the way to the future with a radical new approach to tocotrienol research and manufacturing across cancer, stroke, COVID, and other indications.
This is because tocotrienols represent one of nature’s most powerful antioxidants
We believe that our sophisticated technology has the potential to revolutionize the therapeutic market with tocotrienols at the forefront.
About Us
H&G Science has over 20 years of experience in extracting, nature’s best kept secret, tocotrienols, at high purity, from natural red palm sources.
These compounds, while naturally occurring, are very hard to extract at high purity and scale without our proprietary methodology. However, when the proper purity is achieved The results are astounding.
Across neurological, oncological, anti-inflammatory research and other emerging applications high purity tocotrienols, and their have proved a game changer in study after study for mitigation and prevention of serious conditions like stroke, COVID, cancer, and inflammation.
Our Story
H&G Science’s mission is to provide safer and more effective treatments for cancer and other diseases using sustainable naturally derived products. Our current primary focus is the use of tocotrienols to prevent and treat cancer and other diseases. Tocotrienols, which received GRAS (Generally Recognized As Safe) status from the FDA, are most easily obtained from the naturally occurring red palm fruit. They have been indicated as anti-cancer agents, radiation protecting agents, and preventive agents against many diseases and ailments. H&G Science is positioned to be the first and only supplier of the highly-purified tocotrienol products needed to enter this exciting new market.
The Opportunity
We are actively looking for capital partners to help us flourish. We are uniquely positioned to grow at an unprecedented rate by expanding our research capabilities, market footprint and partnership networks.
Let’s work together.
Leadership Team
Ed Glicken - CEO
Ed has a formal background as an attorney and for nearly 25 years, he has headed operations and business development as CEO, President and VP of Operations at biotechnology companies. He is actively involved in relationships with key researchers and practitioners in natural cancer therapy development.
Kevin Henretta - CTO
Kevin has a formal background in chemistry, 20 years of experience as a commercial scale drug production equipment Design Engineer, and 20 years of experience developing large-scale purification and extraction technologies. Kevin is a leading expert on tocotrienol extraction and purification, as well as other natural and synthetic product purification techniques.